NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 240)
Posted On: 11/11/2020 3:38:42 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. The patent, entitled “System for High Pressure, High Shear Processing of Fluids,” brings the company’s intellectual property (“IP”) estate to a total of 26 issued patents. “Nanoemulsions have long been shown to exhibit improved absorption, higher bioavailability and greater stability, while often requiring lower levels of emulsifiers than macro/micro emulsion products,” said Dr. Edmund Y. Ting, Sr., vice president of engineering of PBI and the inventor on the patent. “Because of these significant advantages, nanoemulsions are currently the focus of numerous research efforts worldwide. However, cost-effective scale-up of high quality nanoemulsion processing at a commercial level continues to be quite challenging. Importantly, we believe that PBI’s innovative and now patented UST platform can provide the key to commercial success for nanoemulsion products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. The patent, entitled “System for High Pressure, High Shear Processing of Fluids,” brings the company’s intellectual property (“IP”) estate to a total of 26 issued patents. “Nanoemulsions have long been shown to exhibit improved absorption, higher bioavailability and greater stability, while often requiring lower levels of emulsifiers than macro/micro emulsion products,” said Dr. Edmund Y. Ting, Sr., vice president of engineering of PBI and the inventor on the patent. “Because of these significant advantages, nanoemulsions are currently the focus of numerous research efforts worldwide. However, cost-effective scale-up of high quality nanoemulsion processing at a commercial level continues to be quite challenging. Importantly, we believe that PBI’s innovative and now patented UST platform can provide the key to commercial success for nanoemulsion products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)